Correlation Between FibroGen and Mastercard Incorporated

Can any of the company-specific risk be diversified away by investing in both FibroGen and Mastercard Incorporated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroGen and Mastercard Incorporated into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FibroGen and Mastercard Incorporated, you can compare the effects of market volatilities on FibroGen and Mastercard Incorporated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroGen with a short position of Mastercard Incorporated. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroGen and Mastercard Incorporated.

Diversification Opportunities for FibroGen and Mastercard Incorporated

-0.08

Correlation Coefficient

FibroGen  Mastercard Incorporated

Good diversification

The 3 months correlation between FibroGen and Mastercard is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and Mastercard Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mastercard Incorporated and FibroGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroGen are associated (or correlated) with Mastercard Incorporated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mastercard Incorporated has no effect on the direction of FibroGen i.e., FibroGen and Mastercard Incorporated go up and down completely randomly.

Pair Corralation between FibroGen and Mastercard Incorporated

Assuming the 90 days trading horizon FibroGen is expected to under-perform the Mastercard Incorporated. In addition to that, FibroGen is 6.92 times more volatile than Mastercard Incorporated. It trades about -0.02 of its total potential returns per unit of risk. Mastercard Incorporated is currently generating about 0.08 per unit of volatility. If you would invest  662,093  in Mastercard Incorporated on September 23, 2024 and sell it today you would earn a total of  396,033  from holding Mastercard Incorporated or generate 59.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

FibroGen  vs.  Mastercard Incorporated

FibroGen

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FibroGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, FibroGen is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mastercard Incorporated

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mastercard Incorporated are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Mastercard Incorporated may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with FibroGen and Mastercard Incorporated

The main advantage of trading using opposite FibroGen and Mastercard Incorporated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroGen position performs unexpectedly, Mastercard Incorporated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mastercard Incorporated will offset losses from the drop in Mastercard Incorporated's long position.

The idea behind FibroGen and Mastercard Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.